Clinical Trials · NCT04086290

National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer Patients

RecruitingPhase 1/Phase 2Gonadorelin (Investigational)
Phase
Phase 1/Phase 2
Recruitment status
Recruiting
Sponsor
Peter Busch Østergren
Enrollment
20
Start date
Oct 2019
Locations
1 site, Denmark
Primary endpoint
Proportion of men with Grade ≥ 3 adverse events the first year
View Gonadorelin compound reference